21 May 2009
Initial experience with renal transplant artery stenosis angioplasty and stenting – it does not conﬁrm antihypertensive or renal function beneﬁtR Kieszek, K Ostrowski, O Rowiński, M Durlik, A Chmura, M Geremek
Ann Transplant 2009; 14(1): 51-51 :: ID: 880385
Background: Transplant renal artery stenosis (TRAS) affects 1-25% of transplant recipients and may lead to allograft loss. The most common presentation is hypertension or elevated serum creatinine concentration (sC); frequently asymptomatic TRAS is seen on routine Doppler US. Objective: To evaluate early results of transplant artery angioplasty in our first referrals from a transplant centre.
Material/Methods: 10 patients (7 male, 3 female, mean age 52.1 years) referred for hypertension (n=3) or elevated sC at various periods post-transplant (4-41 months) were diagnosed with TRAS by Duplex Doppler. All patients underwent balloon angioplasty and 9 had primary stenting. Follow-up ranged from 2 to 21 months with evaluation of arterial blood pressure (ABP), sC, creatinine clearance and the number of antihypertensive drugs taken.
Results: Four patients experienced re-stenosis of the renal transplant artery, three required re-intervention for refractive hypertension. No significant differences were observed pre- and post angioplasty in mean ABP (106.27 vs. 105.36), sC (2.43mg% vs. 2.28m%), creatinine clearance (44.62 vs. 46.9 mL/min) or the number of antihypertensive drugs (3.1 vs. 3.4). There were no graft losses or deaths, dilatation and stent placement were satisfactory at primary angiography in all patients.
Conclusions: Limited experience with a new group of patients does not confirm encouraging results from the other centres in treating hypertension and deteriorating renal graft function secondary to graft's arterial stenosis. A greater number of patients may help to evaluate the impact of endovascular intervention on the long-term graft function, which may be inï¬‚uenced by other factors, such as chronic allograft nephropathy, immunosuppressant nephrotoxicity etc. Satisfactory angiography result is not necessarily reï¬‚ected by the clinical course.
Keywords: Kidney Transplantation
06 May 2022 : Original articlePhosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...
Ann Transplant In Press; DOI: 10.12659/AOT.936293
Most Viewed Current Articles
31 Dec 1969 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
31 Dec 1969 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
31 Dec 1969 : Review articleKidney Transplantation in the Times of COVID-19 – A Literature Review
Ann Transplant 2020; 25:e925755